ALX Oncology Holdings Inc. - Common Stock (NQ:ALXO)

1.220 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ALX Oncology Holdings Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Where ALX Oncology Holdings Stands With Analysts ↗

September 07, 2023

Via Benzinga

ALX Oncology Realigns Executive Leadership Team

September 06, 2023

From ALX Oncology

Via GlobeNewswire

ALX Oncology Announces September Investor Conference Participation

August 31, 2023

From ALX Oncology

Via GlobeNewswire

4 Analysts Have This to Say About ALX Oncology Holdings ↗

August 11, 2023

Via Benzinga

ALX Oncology Reports Second Quarter 2023 Financial Results and Provides Clinical Program Update

August 10, 2023

From ALX Oncology

Via GlobeNewswire

What 4 Analyst Ratings Have To Say About ALX Oncology Holdings ↗

May 12, 2023

Via Benzinga

Recap: ALX Oncology Holdings Q1 Earnings ↗

May 11, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

July 21, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 06, 2023

Via Benzinga

Why Caribou Biosciences Shares Are Trading Higher By Around 58%? Here Are Other Stocks Moving In Thursday's Session ↗

July 06, 2023

Gainers Caribou Biosciences, Inc. (NASDAQ: CRBU) shares jumped 58.1% to $6.45 after the company announced a $25 million equity investment from Pfizer.

Via Benzinga

ALX Oncology Receives Orphan Drug Designation from the European Commission for Evorpacept for the Treatment of Patients with Gastric Cancer

June 26, 2023

From ALX Oncology

Via GlobeNewswire

ALX Oncology Reports First Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights

May 11, 2023

From ALX Oncology

Via GlobeNewswire

ALX Oncology Announces First Patient Dosed in Phase 2 Investigator-Sponsored Trial of Evorpacept in Patients with Ovarian Cancer

May 09, 2023

From ALX Oncology

Via GlobeNewswire

ALX Oncology Announces Clinical Trial Collaboration with Sanofi to Evaluate Evorpacept in Combination with SARCLISA (isatuximab-irfc) in Patients with Multiple Myeloma

April 25, 2023

From ALX Oncology

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 21, 2023

Via Benzinga

ALX Oncology and Quantum Leap Healthcare Collaborative™ Announce First Patient Dosed in the I-SPY-P1 TRIAL in Breast Cancer

March 13, 2023

From ALX Oncology

Via GlobeNewswire

Why SAP Shares Are Trading Higher By Around 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

April 21, 2023

Gainers Mangoceuticals, Inc. (NASDAQ: MGRX) shares jumped 207% to $2.84. The company announced Thursday, that it's featured on Webull Corporate Communications Service Platform.

Via Benzinga

ALX Oncology Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Development and Operational Highlights and Upcoming Milestones

March 09, 2023

From ALX Oncology

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Monday ↗

April 03, 2023

On Monday, 76 companies set new 52-week lows.

Via Benzinga

ALX Oncology Announces First Patient Dosed in ASPEN-07, a Phase 1 Study of Evorpacept for the Treatment of Patients with Urothelial Cancer

February 16, 2023

From ALX Oncology

Via GlobeNewswire

National Instruments, Virgin Galactic And Other Big Stocks Moving Higher On Friday ↗

January 13, 2023

U.S. stocks traded slightly higher, with the Dow Jones gaining around 25 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 10, 2023

Gainers

Via Benzinga

Super Micro Computer, Rayonier Advanced Materials And Some Other Big Stocks Moving Lower On Tuesday ↗

January 10, 2023

U.S. stocks traded slightly higher, with the Dow Jones gaining around 30 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

January 10, 2023

Via Benzinga

ALX Oncology Provides Corporate Update and Highlights Key Milestones in 2023

January 05, 2023

From ALX Oncology

Via GlobeNewswire

ALX Oncology to Present at the 41st Annual J.P. Morgan Healthcare Conference

January 03, 2023

From ALX Oncology

Via GlobeNewswire

AMC Preferred Equity Units, Accolade And Some Other Big Stocks Moving Higher On Friday ↗

December 23, 2022

U.S. stocks traded mixed, with the Dow Jones gaining over 50 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

ALX Oncology Announces Initial Data from ASPEN-05 Study of Evorpacept in Combination with Azacitidine and Venetoclax, Demonstrating Tolerability and Preliminary Activity in Patients with Acute Myeloid Leukemia

December 12, 2022

From ALX Oncology

Via GlobeNewswire

ALX Oncology Appoints Scott Garland to its Board of Directors

November 29, 2022

From ALX Oncology

Via GlobeNewswire

ALX Oncology Reports Third Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights

November 08, 2022

From ALX Oncology

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.